Tag: Cellbased therapies

Browse exclusive Tags!

First Cell-Based Gene Therapies, Casgevy and Lyfgenia, Approved by FDA for Sickle Cell Disease, US

The FDA has approved the first cell-based gene therapies, Casgevy and Lyfgenia, for the treatment of sickle cell disease. Casgevy is the first FDA-approved therapy to use CRISPR/Cas9, a type of genome editing technology. These milestone treatments offer hope for improved outcomes and a better quality of life for patients.

Popular

Subscribe

spot_imgspot_img